Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L&K Biomed is a South Korea-based publicly traded medical device company focused on the development, manufacture, and commercialization of spinal implants and related orthopedic devices. Its portfolio includes cervical, thoracolumbar, minimally invasive, expandable lumbar cage, sacroiliac fixation, and pectus excavatum correction systems sold in Korea, the United States, Thailand, and other international markets. The company appears to generate revenue from commercialized implant systems rather than from a traditional therapeutic drug pipeline. L&K Biomed is best characterized as a spine and orthopedic device manufacturer rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L&K Biomed.